Signalling through retinoic acid receptors is required for reprogramming of both mouse embryonic fibroblast cells and epiblast stem cells to induced pluripotent stem cells

Stem Cells

Volumn 33, Issue 5, 2015, Pages 1390-1404

  Yang, Jian ^a   Wang, Wei ^a   Ooi, Jolene ^a   Campos, Lia S ^a   Lu, Liming ^a,b   Liu, Pentao ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Epiblast stem cells; Induced pluripotent stem cells; Liver receptor homolog 1; Reprogramming; Retinoic acid receptor gamma; Retinoic acid receptors; Catenin

Indexed keywords

BETA CATENIN; LIVER RECEPTOR HOMOLOG 1; RETINOIC ACID RECEPTOR; RETINOID; LIGAND; RETINOIC ACID; RETINOIC ACID RECEPTOR GAMMA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ECTODERM; EMBRYO; EMBRYONIC STEM CELL; FEEDER CELL; FIBROBLAST; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; SOMATIC CELL; ANIMAL; CYTOLOGY; GERM LAYER; INDUCED PLURIPOTENT STEM CELL; MAMMALIAN EMBRYO; METABOLISM; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; CELLULAR REPROGRAMMING; EMBRYO, MAMMALIAN; FIBROBLASTS; GERM LAYERS; INDUCED PLURIPOTENT STEM CELLS; LIGANDS; MICE; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRETINOIN; WNT SIGNALING PATHWAY;

EID: 84928526816     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1926     Document Type: Article

References (73)

1. Takahashi K, Yamanaka S,. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
2. Hamanaka S, Yamaguchi T, Kobayashi T, et al. Generation of germline-competent rat induced pluripotent stem cells. PLoS One 2011; 6: 15.
3. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
4. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-1920.
5. Huangfu D, Maehr R, Guo W, et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008; 26: 795-797.
6. Esteban MA, Wang T, Qin B, et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 2010; 6: 71-79.
7. Chen J, Liu H, Liu J, et al. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat Genet 2013; 45: 34-42.
8. Lyssiotis CA, Foreman RK, Staerk J, et al. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci USA 2009; 106: 8912-8917.
9. Ichida JK, Blanchard J, Lam K, et al. A small-molecule inhibitor of tgf-beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 2009; 5: 491-503.
10. Hou P, Li Y, Zhang X, et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 2013; 341: 651-654.
11. Yang J, van Oosten AL, Theunissen TW, et al. Stat3 activation is limiting for reprogramming to ground state pluripotency. Cell Stem Cell 2010; 7: 319-328.
12. Silva J, Barrandon O, Nichols J, et al. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 2008; 6: e253.
13. Wang W, Yang J, Liu H, et al. Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proc Natl Acad Sci USA 2011; 108: 18283-18288.
14. Brun PJ, Yang KJ, Lee SA, et al. Retinoids: Potent regulators of metabolism. Biofactors 2013; 39: 151-163.
15. Heyman RA, Mangelsdorf DJ, Dyck JA, et al. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992; 68: 397-406.
16. Niederreither K, Dolle P,. Retinoic acid in development: Towards an integrated view. Nat Rev Genet 2008; 9: 541-553.
17. Mark M, Ghyselinck NB, Chambon P,. Function of retinoic acid receptors during embryonic development. Nucl Recept Signal 2009; 7: 3.
18. Lefebvre P, Martin PJ, Flajollet S, et al. Transcriptional activities of retinoic acid receptors. Vitam Horm 2005; 70: 199-264.
19. Pikarsky E, Sharir H, Ben-Shushan E, et al. Retinoic acid represses Oct-3/4 gene expression through several retinoic acid-responsive elements located in the promoter-enhancer region. Mol Cell Biol 1994; 14: 1026-1038.
20. Chang L, Wei LN,. Characterization of a negative response DNA element in the upstream region of the cellular retinoic acid-binding protein-I gene of the mouse. J Biol Chem 1997; 272: 10144-10150.
21. Soprano DR, Teets BW, Soprano KJ,. Role of retinoic acid in the differentiation of embryonal carcinoma and embryonic stem cells. Vitam Horm 2007; 75: 69-95.
22. Boylan JF, Lufkin T, Achkar CC, et al. Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol Cell Biol 1995; 15: 843-851.
23. Nichols J, Ying QL,. Derivation and propagation of embryonic stem cells in serum- and feeder-free culture. Methods Mol Biol 2006; 329: 91-98.
24. Ying QL, Wray J, Nichols J, et al. The ground state of embryonic stem cell self-renewal. Nature 2008; 453: 519-523.
25. Guo G, Yang J, Nichols J, et al. Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 2009; 136: 1063-1069.
26. Spoerri PE, Heyder H, Eins S,. Growth of mouse neuroblastoma cell line in a defined medium. Neurosci Lett 1983; 37: 313-318.
27. Brewer GJ, Torricelli JR, Evege EK, et al. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res 1993; 35: 567-576.
28. Ying QL, Nichols J, Chambers I, et al. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 2003; 115: 281-292.
29. Guo G, Huang Y, Humphreys P, et al. A PiggyBac-based recessive screening method to identify pluripotency regulators. PLoS One 2011; 6: 0018189.
30. Brons IG, Smithers LE, Trotter MW, et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007; 448: 191-195.
31. Toyooka Y, Shimosato D, Murakami K, et al. Identification and characterization of subpopulations in undifferentiated ES cell culture. Development 2008; 135: 909-918.
32. Buehr M, Meek S, Blair K, et al. Capture of authentic embryonic stem cells from rat blastocysts. Cell 2008; 135: 1287-1298.
33. Okita K, Nakagawa M, Hyenjong H, et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322: 949-953.
34. Warren L, Manos PD, Ahfeldt T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010; 7: 618-630.
35. Fusaki N, Ban H, Nishiyama A, et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B: Phys Biol Sci 2009; 85: 348-362.
36. Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324: 797-801.
37. Leight ER, Sugden B,. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol Cell Biol 2001; 21: 4149-4161.
38. Wang Y, Chen J, Hu JL, et al. Reprogramming of mouse and human somatic cells by high-performance engineered factors. EMBO Rep 2011; 12: 373-378.
39. De Ruyter MG, Lambert WE, De Leenheer AP,. Retinoic acid: An endogenous compound of human blood. Unequivocal demonstration of endogenous retinoic acid in normal physiological conditions. Anal Biochem 1979; 98: 402-409.
40. Hoffman LM, Garcha K, Karamboulas K, et al. BMP action in skeletogenesis involves attenuation of retinoid signaling. J Cell Biol 2006; 174: 101-113.
41. Hanna J, Saha K, Pando B, et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009; 462: 595-601.
42. Crowe DL, Kim R, Chandraratna RA,. Retinoic acid differentially regulates cancer cell proliferation via dose-dependent modulation of the mitogen-activated protein kinase pathway. Mol Cancer Res 2003; 1: 532-540.
43. Wang JL, Swartz-Basile DA, Rubin DC, et al. Retinoic acid stimulates early cellular proliferation in the adapting remnant rat small intestine after partial resection. J Nutr 1997; 127: 1297-1303.
44. Ben-Shushan E, Sharir H, Pikarsky E, et al. A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells. Mol Cell Biol 1995; 15: 1034-1048.
45. Barnea E, Bergman Y,. Synergy of SF1 and RAR in activation of Oct-3/4 promoter. J Biol Chem 2000; 275: 6608-6619.
46. Heng JC, Feng B, Han J, et al. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 2010; 6: 167-174.
47. Engberg N, Kahn M, Petersen DR, et al. Retinoic acid synthesis promotes development of neural progenitors from mouse embryonic stem cells by suppressing endogenous, Wnt-dependent nodal signaling. Stem Cells 2010; 28: 1498-1509.
48. Di Renzo F, Broccia ML, Giavini E, et al. Citral, an inhibitor of retinoic acid synthesis, attenuates the frequency and severity of branchial arch abnormalities induced by triazole-derivative fluconazole in rat embryos cultured in vitro. Reprod Toxicol 2007; 24: 326-332.
49. Tsai S, Bartelmez S, Heyman R, et al. A mutated retinoic acid receptor-alpha exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes Dev 1992; 6: 2258-2269.
50. Nichols J, Smith A,. Naive and primed pluripotent states. Cell Stem Cell 2009; 4: 487-492.
51. Silva J, Nichols J, Theunissen TW, et al. Nanog is the gateway to the pluripotent ground state. Cell 2009; 138: 722-737.
52. Guo G, Smith A,. A genome-wide screen in EpiSCs identifies Nr5a nuclear receptors as potent inducers of ground state pluripotency. Development 2010; 137: 3185-3192.
53. Doble BW, Woodgett JR,. GSK-3: Tricks of the trade for a multi-tasking kinase. J Cell Sci 2003; 116: 1175-1186.
54. Martello G, Sugimoto T, Diamanti E, et al. Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell 2012; 11: 491-504.
55. Wray J, Kalkan T, Gomez-Lopez S, et al. Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nat Cell Biol 2011; 13: 838-845.
56. Yi F, Pereira L, Hoffman JA, et al. Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal. Nat Cell Biol 2011; 13: 762-770.
57. Chen Y, Blair K, Smith A,. Robust self-renewal of rat embryonic stem cells requires fine-tuning of glycogen synthase kinase-3 inhibition. Stem Cell Rep 2013; 1: 209-217.
58. Molenaar M, van de Wetering M, Oosterwegel M, et al. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 1996; 86: 391-399.
59. Easwaran V, Pishvaian M, Salimuddin, et al. Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways. Curr Biol 1999; 9: 1415-1418.
60. Chen B, Dodge ME, Tang W, et al. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 2009; 5: 100-107.
61. Stadtfeld M, Hochedlinger K,. Induced pluripotency: History, mechanisms, and applications. Genes Dev 2010; 24: 2239-2263.
62. Chen J, Liu J, Chen Y, et al. Rational optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells with ultra-high efficiency and fast kinetics. Cell Res 2011; 21: 884-894.
63. Guan K, Chang H, Rolletschek A, et al. Embryonic stem cell-derived neurogenesis. Retinoic acid induction and lineage selection of neuronal cells. Cell Tissue Res 2001; 305: 171-176.
64. Micallef SJ, Janes ME, Knezevic K, et al. Retinoic acid induces Pdx1-positive endoderm in differentiating mouse embryonic stem cells. Diabetes 2005; 54: 301-305.
65. Torres J, Prieto J, Durupt FC, et al. Efficient differentiation of embryonic stem cells into mesodermal precursors by BMP, retinoic acid and Notch signalling. PLoS One 2012; 7: 30.
66. Laursen KB, Wong PM, Gudas LJ,. Epigenetic regulation by RARalpha maintains ligand-independent transcriptional activity. Nucleic Acids Res 2012; 40: 102-115.
67. Hua S, Kittler R, White KP,. Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell 2009; 137: 1259-1271.
68. Ross-Innes CS, Stark R, Holmes KA, et al. Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. Genes Dev 2010; 24: 171-182.
69. Lluis F, Pedone E, Pepe S, et al. Periodic activation of Wnt/beta-catenin signaling enhances somatic cell reprogramming mediated by cell fusion. Cell Stem Cell 2008; 3: 493-507.
70. Marson A, Foreman R, Chevalier B, et al. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 2008; 3(2): 132-135.
71. Lluis F, Ombrato L, Pedone E, et al. T-cell factor 3 (Tcf3) deletion increases somatic cell reprogramming by inducing epigenome modifications. Proc Natl Acad Sci USA 2011; 108: 11912-11917.
72. Zhang P, Chang WH, Fong B, et al. Regulation of induced pluripotent stem (iPS) cell induction by Wnt/beta-catenin signaling. J Biol Chem 2014; 289: 9221-9232.
73. Ho R, Papp B, Hoffman JA, et al. Stage-specific regulation of reprogramming to induced pluripotent stem cells by Wnt signaling and T cell factor proteins. Cell Rep 2013; 3: 2113-2126.